Neuro-Oncology
Reviews


Volume 21 Number 6
June 2019


Home > Publications > Neuro-Oncology Reviews > Volume 21, Year 2019 > Number 6, June




Awadalla AS, Al Essa AM, Al Ahmadi HH, Al Ojan A, Muazen Y, Alsayyah A, Alsaif H, Alsafwani NS.
Gliosarcoma case report and review of the literature.
Pan Afr Med J. 2019 Jun 27. 2019;20:914-919. doi: 10.12659/AJCR.916020. _



























Central nervous system tumors


Abd-Ellah MK, Awad AI, Khalaf AAM, Hamed HFA.
A review on brain tumor diagnosis from MRI images: Practical implications, key achievements, and lessons learned.
Magn Reson Imaging. 2019 Jun 5. 2019;61:300-318. doi: 10.1016/j.mri.2019.05.028. _




Chi AS et al, PDQ Adult Treatment Editorial Board.
Adult Central Nervous System Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 May 3. _




Jalali R, Goda JS.
Proton beam therapy in pediatric brain tumor patients: Improved radiation delivery techniques improve neurocognitive outcomes.
Neuro Oncol. 2019 May 13. doi: 10.1093/neuonc/noz085. _




Kaley T, Nabors LB.
Management of Central Nervous System Tumors.
J Natl Compr Canc Netw. 2019 May 1. 2019;17(5.5):579-582. doi: 10.6004/jnccn.2019.5012. _




Kondziolka D.
Current and novel practice of stereotactic radiosurgery.
J Neurosurg. 2019 Jun 1. 2019;130(6):1789-1798. doi: 10.3171/2019.2.JNS181712. _




Lu VM, Rechberger JS, Himes BT, Daniels DJ.
The 100 Most-Cited Articles About Convection-Enhanced Delivery to the Brain: A Bibliometric Analysis.
World Neurosurg. 2019 May 29. doi: 10.1016/j.wneu.2019.05.179. _




Wang SS, Bandopadhayay P, Jenkins MR.
Towards Immunotherapy for Pediatric Brain Tumors.
Trends Immunol. 2019 Jun 19. doi: 10.1016/j.it.2019.05.009. _



Gliomas


Liang S, Fan X, Zhao M, Shan X, Li W, Ding P, You G, Hong Z, Yang X, Luan G, Ma W, Yang H, You Y, Yang T, Li L, Liao W, Wang L, Wu X, Yu X, Zhang J, Mao Q, Wang Y, Li W, Wang X, Jiang C, Liu X, Qi S, Liu X, Qu Y, Xu J, Wang W, Song Z, Wu J, Liu Z, Chen L, Lin Y, Zhou J, Liu X, Zhang W, Li S, Jiang T.
Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy.
Cancer Med. 2019 Jun 26. doi: 10.1002/cam4.2362. _




Walsh KM, Claus EB.
Diet and risk of glioma: targets for prevention remain elusive.
Neuro Oncol. 2019 Apr 23. doi: 10.1093/neuonc/noz074. _



High-grade gliomas



Hua L, Wakimoto H.
Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application.
Expert Opin Biol Ther. 2019 May 2. 2019:1-10. doi: 10.1080/14712598.2019.1614557. _




Yamaguchi F.
The Border Zone of Tumor. Where is the Border? What is a Surgical Border for Patients?
World Neurosurg X. 2019 Jan 24. 2019;2:100011. doi: 10.1016/j.wnsx.2019.100011. _
Comment on: Chang KT et al, In Vivo Real-Time Discrimination Among Glioma, Infiltration Zone, and Normal Brain Tissue via Autofluorescence Technology. World Neurosurg. 2018 Nov 1. 2019;122:e773-e782. doi: 10.1016/j.wneu.2018.10.144. _



Low-grade gliomas



Ferracci FX, Michaud K, Duffau H.
The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas.
Crit Rev Oncol Hematol. 2019 Apr 15. 2019;138:148-155. doi: 10.1016/j.critrevonc.2019.04.009. _




Jooma R, Waqas M, Khan I.
Diffuse Low-Grade Glioma - Changing Concepts in Diagnosis and Management: A Review.
Asian J Neurosurg. 2019 Apr 26. 2019;14(2):356-363. doi: 10.4103/ajns.AJNS_24_18. _




Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS.
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?
Am Soc Clin Oncol Educ Book. 2019 May 17. 2019;39:133-145. doi: 10.1200/EDBK_238353. _



Diffuse astrocytic and oligodendroglial tumors



Glioblastoma



Altmann C, Keller S, Schmidt MHH.
The Role of SVZ Stem Cells in Glioblastoma.
Cancers (Basel). 2019 Mar 29;11(4):448. doi: 10.3390/cancers11040448. PMID: 30934929. Review.




Arora A, Somasundaram K.
Glioblastoma vs temozolomide: can the red queen race be won?
Cancer Biol Ther. 2019 May 8. 2019;20(8):1083-1090. doi: 10.1080/15384047.2019.1599662. _




Behnan J, Finocchiaro G, Hanna G.
The landscape of the mesenchymal signature in brain tumours.
Brain. 2019 Apr 1. 2019;142(4):847-866. doi: 10.1093/brain/awz044. _




Carvalho JADV, Barbosa CCL, Feher O, Maldaun MVC, Camargo VP, Moraes FY, Marta GN.
Systemic dissemination of glioblastoma: literature review.
Rev Assoc Med Bras (1992). 2019 Apr 11. 2019;65(3):460-468. doi: 10.1590/1806-9282.65.3.460. _




Chaddad A, Kucharczyk MJ, Daniel P, Sabri S, Jean-Claude BJ, Niazi T, Abdulkarim B.
Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation.
Front Oncol. 2019 May 21. 2019;9:374. doi: 10.3389/fonc.2019.00374. _




Chuang DF, Lin X.
Targeted Therapies for the Treatment of Glioblastoma in Adults.
Curr Oncol Rep. 2019 May 17. 2019;21(7):61. doi: 10.1007/s11912-019-0807-1. _




Cohen-Inbar O.
Geriatric brain tumor management part II: Glioblastoma multiforme.
J Clin Neurosci. 2019 Jun 18. doi: 10.1016/j.jocn.2019.05.064. _




Cunha MLVD, Maldaun MVC.
Metastasis from glioblastoma multiforme: a meta-analysis.
Rev Assoc Med Bras (1992). 2019 Apr 11. 2019;65(3):424-433. doi: 10.1590/1806-9282.65.3.424. _




Gimple RC, Bhargava S, Dixit D, Rich JN.
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.
Genes Dev. 2019 Jun 1. 2019;33(11-12):591-609. doi: 10.1101/gad.324301.119. _




Hide T, Shibahara I, Kumabe T.
Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features.
Brain Tumor Pathol. 2019 Apr 9. 2019;36(2):63-73. doi: 10.1007/s10014-019-00341-2. _




Kim IH.
Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation.
Radiat Oncol J. 2019 Mar 31. 2019;37(1):1-12. doi: 10.3857/roj.2019.00171. _




Kim YZ, Kim CY, Lim J, Sung KS, Lee J, Oh HJ, Kang SG, Kang SH, Kong DS, Kim SH, Kim SH, Kim SH, Kim YJ, Kim EH, Kim IA, Kim HS, Roh TH, Park JS, Park HJ, Song SW, Yang SH, Yoon WS, Yoon HI, Lee ST, Lee SW, Lee YS, Wee CW, Chang JH, Jung TY, Jung HL, Cho JH, Choi SH, Choi HS, Hong JB, Lim DH, Chung DS; KSNO Guideline Working Group.
The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01.
Brain Tumor Res Treat. 2019 Apr 30. 2019;7(1):1-9. doi: 10.14791/btrt.2019.7.e25. _




Klekner Á, Szivos L, Virga J, Árkosy P, Bognár L, Birkó Z, Nagy B.
Significance of liquid biopsy in glioblastoma - A review.
J Biotechnol. 2019 Apr 12. 2019;298:82-87. doi: 10.1016/j.jbiotec.2019.04.011. _




McConnell DD, Carr SB, Litofsky NS.
Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review.
Expert Rev Neurother. 2019 May 17. 2019;19(6):545-555. doi: 10.1080/14737175.2019.1617701. _




Mooney J, Bernstock JD, Ilyas A, Ibrahim A, Yamashita D, Markert JM, Nakano I.
Current approaches and challenges in the molecular therapeutic targeting of glioblastoma.
World Neurosurg. 2019 May 29. doi: 10.1016/j.wneu.2019.05.205. _




Riley MM, San P, Lok E, Swanson KD, Wong ET.
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
J Vis Exp. 2019 Apr 16. 2019;(146). doi: 10.3791/58937. _




Zhao YH, Wang ZF, Pan ZY, Péus D, Delgado-Fernandez J, Pallud J, Li ZQ.
A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation.
Front Neurol. 2019 Mar 26. 2019;10:286. doi: 10.3389/fneur.2019.00286. _



Gliosarcoma



Saadeh F, El Iskandarani S, Najjar M, Assi HI.
Prognosis and management of gliosarcoma patients: A review of literature.
Clin Neurol Neurosurg. 2019 May 14. 2019;182:98-103. doi: 10.1016/j.clineuro.2019.05.008. _



Diffuse midline glioma


*

Lu VM, Power EA, Kerezoudis P, Daniels DJ.
The 100 most-cited articles about diffuse intrinsic pontine glioma: a bibliometric analysis.
Childs Nerv Syst. 2019 Jun 15;35(12):2339-2346. doi: 10.1007/s00381-019-04254-5. PMID: 31203394. Bibliometric analysis.



Embryonal tumors



Medulloblastoma



Majd N, Penas-Prado M.
Updates on Management of Adult Medulloblastoma.
Curr Treat Options Oncol. 2019 Jun 24. 2019;20(8):64. doi: 10.1007/s11864-019-0663-0. _




Thomas A, Noël G.
Medulloblastoma: optimizing care with a multidisciplinary approach.
J Multidiscip Healthc. 2019 Apr 30. 2019;12:335-347. doi: 10.2147/JMDH.S167808. _



Meningiomas



Meningioma



Cohen-Inbar O.
Geriatric brain tumor management part I: Meningioma.
J Clin Neurosci. 2019 Jun 14. doi: 10.1016/j.jocn.2019.05.063. _



Familial tumor syndromes


Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S.
An update on the CNS manifestations of neurofibromatosis type 2.
Acta Neuropathol. 2019 Jun 4. doi: 10.1007/s00401-019-02029-5. _



bottom